Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Wilson

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growthChristopher W Gregory, Young E Whang, Wesley McCall, et al.
Cell|August 10, 2010
Insights into antiparallel microtubule crosslinking by PRC1, a conserved nonmotor microtubule binding proteinRadhika Subramanian, Elizabeth M Wilson-Kubalek, Christopher P Arthur, et al.
The Journal of Biological Chemistry|September 10, 2010
An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophyChristopher R Orr, Heather L Montie, Yuhong Liu, et al.
Nature|January 7, 2014
Selection and evaluation of clinically relevant AAV variants in a xenograft liver modelLeszek Lisowski, Allison P Dane, Kirk Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate CancerMark A Titus, Jiann-An Tan, Christopher W Gregory, et al.
The Journal of Biological Chemistry|November 3, 2010
A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}Nicole M Kretzer, Milu T Cherian, Chengjian Mao, et al.
Molecular Cell|November 5, 2004
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominanceBin He, Robert T Gampe, Adam J Kole, et al.
Molecular and Cellular Endocrinology|October 10, 2013
Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancerJiann-An Tan, Suxia Bai, Gail Grossman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 20, 2021
Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding ProteinsLiberta Cuko, Zofia Duniec-Dmuchowski, Elizabeth A Rondini, et al.
Cardiology in the Young|April 1, 2011
Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumaticRachel H Webb, Nigel J Wilson, Diana R Lennon, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growthChristopher W Gregory, Young E Whang, Wesley McCall, et al.
Cell|August 10, 2010
Insights into antiparallel microtubule crosslinking by PRC1, a conserved nonmotor microtubule binding proteinRadhika Subramanian, Elizabeth M Wilson-Kubalek, Christopher P Arthur, et al.
The Journal of Biological Chemistry|September 10, 2010
An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophyChristopher R Orr, Heather L Montie, Yuhong Liu, et al.
Nature|January 7, 2014
Selection and evaluation of clinically relevant AAV variants in a xenograft liver modelLeszek Lisowski, Allison P Dane, Kirk Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate CancerMark A Titus, Jiann-An Tan, Christopher W Gregory, et al.
The Journal of Biological Chemistry|November 3, 2010
A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}Nicole M Kretzer, Milu T Cherian, Chengjian Mao, et al.
Molecular Cell|November 5, 2004
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominanceBin He, Robert T Gampe, Adam J Kole, et al.
Molecular and Cellular Endocrinology|October 10, 2013
Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancerJiann-An Tan, Suxia Bai, Gail Grossman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 20, 2021
Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding ProteinsLiberta Cuko, Zofia Duniec-Dmuchowski, Elizabeth A Rondini, et al.
Cardiology in the Young|April 1, 2011
Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumaticRachel H Webb, Nigel J Wilson, Diana R Lennon, et al.
Pageof 11